Holen Sie sich die Stockscreener-App
53.35
1.68%
-0.91
Handel nachbörslich:
53.35
Ani Pharmaceuticals Inc Aktie (ANIP) Neueste Nachrichten
Wellington Management Group LLP Lowers Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - MarketBeat
State Street Corp Acquires 58,698 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - MarketBeat
Insider Sell: Stephen Carey Sells 7,500 Shares of ANI Pharmaceuticals Inc (ANIP) - GuruFocus.com
Stephen P. Carey Sells 7,500 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Stock - MarketBeat
Ani Pharmaceuticals CFO sells $418,425 in stock By Investing.com - Investing.com South Africa
Ani Pharmaceuticals CFO sells $418,425 in stock - Investing.com
Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock? - Yahoo Finance
ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) Prospects Need A Boost To Lift Shares - Simply Wall St
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Shares Bought by Barclays PLC - MarketBeat
Ani Pharmaceuticals Sr. VP Meredith Cook sells $14,060 in stock - Investing.com
Ani Pharmaceuticals Sr. VP Meredith Cook sells $14,060 in stock By Investing.com - Investing.com Australia
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $2.03 Million Stake in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - MarketBeat
Key Pharmaceutical Suspension Market Trend 2024-2033: ANI Pharmaceuticals Launches Kionex Suspension - EIN News
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Sees Significant Decrease in Short Interest - MarketBeat
Insider Sell: Krista Davis Sells 1,000 Shares of ANI Pharmaceuti - GuruFocus.com
ANI Pharmaceuticals (NASDAQ:ANIP) Upgraded to "Strong-Buy" at Leerink Partnrs - MarketBeat
Leerink Partners Initiates Coverage of ANI Pharmaceuticals (ANIP) with Outperform Recommendation - MSN
ANI Pharmaceuticals (NASDAQ:ANIP) Now Covered by Analysts at Leerink Partners - MarketBeat
Where ANI Pharmaceuticals Stands With Analysts - Benzinga
Charles Schwab Investment Management Inc. Buys 8,869 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - MarketBeat
Hotchkis & Wiley Capital Management LLC Buys Shares of 52,080 ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - MarketBeat
Are Medical Stocks Lagging Adagene (ADAG) This Year? - Yahoo Finance
Intrauterine Devices Market Report Forecasts and Company - GlobeNewswire
Intrauterine Devices Market Report Forecasts and Company Analysis 2024-2032, Profiles of AbbVie, Bayer, Teva Pharmaceuticals, ANI Pharmaceuticals, Mylan, CooperSurgical. and DKT International - Yahoo Finance
Ani Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 - Marketscreener.com
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Martingale Asset Management L P Purchases 13,719 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - MarketBeat
Bank of Montreal Can Makes New $13.04 Million Investment in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - MarketBeat
ANI Pharmaceuticals (NASDAQ:ANIP) Shares Down 2.9%Here's Why - MarketBeat
Intech Investment Management LLC Acquires New Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - MarketBeat
Ani Pharmaceuticals Insider Sold Shares Worth $1,941,442, According to a Recent SEC Filing - Marketscreener.com
Ani Pharmaceuticals CEO Nikhil Lalwani sells $1.94 million in stock - Investing.com India
Ani Pharmaceuticals CEO Nikhil Lalwani sells $1.94 million in stock By Investing.com - Investing.com Australia
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Stock Holdings Decreased by Rubric Capital Management LP - MarketBeat
Gastroparesis Drugs Market to Grow by USD 1.42 Billion (2024-2028), Diabetes Burden Boosts Growth, AI Impact on Market TrendsTechnavio - The Malaysian Reserve
ANI Pharmaceuticals to Present at 36th Annual Piper Sandler Healthcare Conference - The Manila Times
Eagle Asset Management Inc. Purchases New Position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - MarketBeat
ANI Pharmaceuticals CEO to Present at Piper Sandler Healthcare Conference - StockTitan
Pacer Advisors Inc. Acquires 565,910 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - MarketBeat
Thompson Siegel & Walmsley LLC Raises Stake in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - MarketBeat
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Shares Purchased by Global Alpha Capital Management Ltd. - MarketBeat
Don't Ignore The Insider Selling In ANI Pharmaceuticals - Simply Wall St
ANI Pharmaceuticals Q3 2024 Earnings Preview - MSN
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Short Interest Update - MarketBeat
Mizuho Markets Americas LLC Makes New $11.67 Million Investment in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - MarketBeat
Athlete′s Foot Drugs Market: Global Trends, Demand, - openPR
Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now? - Yahoo Finance
Rubric Capital Management LP Adjusts Stake in ANI Pharmaceuticals Inc - GuruFocus.com
ANI Pharmaceuticals Inc (ANIP) Stock Price Up 2.37% on Nov 13 - GuruFocus.com
Lisanti Capital Growth LLC Has $890,000 Stock Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - MarketBeat
ANI Pharmaceuticals maintains Buy rating, target at $94 By Investing.com - Investing.com UK
HC Wainwright Reaffirms Buy Rating for ANI Pharmaceuticals (NASDAQ:ANIP) - MarketBeat
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q3 2024 Earnings Call Transcript - Insider Monkey
1.61%
1.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):